0.33% Erythego Gel
Erythego Gel 0.33% is a topical medication manufactured by Akumentis Healthcare Ltd., formulated to treat the symptoms of rosacea, particularly facial erythema (redness). The activ...
In Stock
0.33% Erythego Gel
Erythego Gel 0.33% is a topical medication manufactured by Akumentis Healthcare Ltd., formulated to treat the symptoms of rosacea, particularly facial erythema (redness). The active ingredient, Brimonidine, is an alpha-2 adrenergic agonist that works by constricting the dilated blood vessels in the skin, thereby reducing redness and flushing associated with rosacea. This gel is designed for external use only and is typically applied once daily to the affected areas of the face.
| Strength | 0.33 |
| Form | Ophthalmic Solution |
